ArticleNeuropsychiatric disease and treatment2019

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And Schizophrenia.

Ashish Kumar Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.